Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 8.5B | 8.2B | 8.1B | 7.4B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 2.1B | 2.0B | 2.0B | 1.9B |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 3.6B | 3.6B | 3.6B | 3.3B |
| Tax provision | 750M | 750M | 730M | 700M |
| Net income | 2.9B | 2.9B | 2.9B | 2.6B |
| Basic EPS | — | 3.9 | 3.9 | 3.6 |
| Diluted EPS | — | 3.8 | 3.8 | 3.5 |
| Basic average shares | — | 740.9M | 740.7M | 740.9M |
| Diluted average shares | — | 746.7M | 746.5M | 747.1M |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |